Dedifferentiated Liposarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-04-14
Clinical Trial Update: Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma [Phase 2]
A Phase 2 trial evaluating IPI-504 for advanced dedifferentiated liposarcoma was withdrawn.